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Abstract
We investigated substrate dependent paracrine signaling between subpopulations of bone marrow stromal cells (BMSCs)
that may affect the formation, or perhaps malformation, of the regenerating tendon to bone enthesis. Polyacrylamide
substrates approximating the elastic modulus of tendon granulation tissue and the osteoid of healing bone (10–90 kPa)
were functionalized with whole length fibronectin (Fn), type-I collagen (Col), or a mixed ligand solution (Fn/Col), and BMSCs
were cultured in growth media alone or media supplemented with soluble Col or Fn. More rigid substrates with a narrow
mechanical gradient (70–90 kPa) robustly induced osteogenic cell differentiation when functionalized with either Col or Fn.
On broader mechanical gradient substrates (with a linear elastic modulus gradient from 10–90 kPa), cell differentiation was
markedly osteogenic on subregions of Fn functionalized substrates above 20 kPa, but osteogenic activity was inhibited on
all subregions of Col substrates. Osteogenic behavior was not observed when cells were cultured on Fn substrates if Col was
present either in the media or on the substrate (Fn/Col). Tenogenic differentiation markers were observed only on Col
substrates with moderate rigidity (,30–50 kPa). Tenogenic differentiation was unaltered by soluble or substrate bound Fn.
Co-culture of narrow gradient subsections revealed that any inclusion of tenogenic substrates (30–50 kPa, Col), caused
otherwise osteogenic substrates to not develop markers of osteogenic differentiation, while increasing cell proliferation.
These apparently paracrine effects could be mediated by bone morphogenetic protein-2 (BMP-2), as first confirmed by
gene-level expression of BMP-2 and the transcription factor Smad8, and verified by BMP-2 media supplementation at levels
similar to observed cell-secreted concentrations, which arrested osteogenic differentiation in 14 day cultures. Thus, cell
instructive biomaterials with engineered mechanical and biochemical properties represent potentially powerful tools for
directing BMSC differentiation to tendon and bone, however paracrine signals from tenogenic cells may delay osteogenesis
at the healing enthesis.
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Introduction
The native tendon to bone junction is an exquisitely designed
tissue interface comprising a cellular transition from the tendon
itself, to a non-mineralized fibrocartilage region, to a mineralized
fibrocartilage region, and ultimately to the bone [1,2]. Post-
traumatic healing of tendon to bone is generally poor, due in part
to the competing objectives of a rapid recovery of joint function
and the tissue complexity required for a mechanically robust
interface [3]. BMSCs are highly relevant in the context of healing,
being recruited to skeletal tissue damage as well as other major
organs of the body including the heart, brain, liver, and skin [4].
Once recruited, BMSCs become actively involved in wound
healing processes such as epithelialization, granulation tissue
formation, and angiogenesis [5,6,7]. When a BMSC homes to
an injury site, its behavior at the site is directed by a complex set of
micro-environmental factors that include soluble and substrate-
bound cues in the extracellular matrix, and intracellular signaling
in the wound [8]. Homed BMSCs eventually participate in tissue
repair in two manners: first by proliferation and eventual
differentiation to appropriate numbers and phenotypes of cells
required for healing, and second by mediating the behavior of cells
involved in the repair process through paracrine signaling [9,10].
BMSCs can secrete trophic factors that are highly stimulatory
to tendon and bone extracellular matrix production and tissue
remodeling, including growth factors such as transforming growth
factor beta (TGF-b) and bone morphogenetic protein 2 (BMP-2)
[11,12], which can play a role in regulating differentiation and
healing kinetics [13]. However, the interactions between BMSC
paracrine signaling and extracellular matrix cues and how they
affect progenitor cell differentiation at the healing tendon to bone
interface remains to be elucidated.
We previously demonstrated that BMSCs could be differentially
induced to commit toward bone and tendon cell lineages using
engineered substrates of given ligand chemistry and mechanical
compliance [14]. Here, biochemical and biomechanical cues were
shown to regulate mitogen activated protein (MAP) kinase
signaling, and directly affect gene level expression of transcription
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factors related to tenogenic and osteogenic differentiation [15,16].
We utilized polyacrylamide hydrogels featuring a gradient of
mechanical compliance spanning a range similar to granulation
tissue. On these mechanical gradient substrates (MG substrates;
spanning a range of moduli from 10–90 kPa) we focused on
fibronectin as an extracellular matrix glycoprotein that plays a
major role in cell dynamics like adhesion and migration during
processes such as wound healing, development, and differentiation
[17]. We also investigated type-I collagen, a key structural protein
in both tendon and bone tissue [18] and the most abundant
protein in skeletal connective tissues [19]. Although we were able
to report for the first time induction of tenogenic differentiation
using such substrates, we were unable to reach our original goal of
creating localized regions of both tendon and bone-like cell
lineages on the same gradient substrate; tenogenic cells were found
only on the intermediate compliance region of collagen MG
substrates (,40 kPa), while osteogenic cells were increasingly
localized on higher stiffness subregions of fibronectin MG
substrates (above 40 kPa). It was particularly interesting to note
that the stiffest regions of collagen MG substrates did not result in
osteogenic cells as reported in previous studies using analogous
systems with mechanically isotropic properties [20]. We conjec-
tured that cell-cell contacts or paracrine signaling from various
regions of the gradient stiffness substrate may have interfered with
osteogenic differentiation in some cases, and thus prevented
multiple cell lineages from forming on the mechanical gradient
substrates.
In the present work we focused on the hypothesis that cell
secreted cues can affect bone marrow stromal cell (BMSC)
differentiation across remote sites of a MG substrate, and that
these cues depend on both ligand chemistry and substrate
stiffness. As before, we examined BMSC differentiation toward
tenogenic and osteogenic lineages on gradient stiffness substrates
functionalized with type-I collagen or fibronectin, but also
explored mixed ligand functionalization, and the effects of
stimulation by soluble fibronectin or collagen. To exclude the
influence of cell-cell contacts across stiffness regions, we
performed similar experiments using subsections of the broader
mechanical gradient in the same culture well. We confirmed our
hypothesis that cell-secreted (paracrine) cues from the tenoge-
nic substrates could affect osteogenic differentiation within the
system. We identified elevated signaling related to bone
morphogenetic protein-2 (BMP-2) in tenogenic cultures that
apparently interfered with (or delayed) the onset of osteogenic
markers at the day 14 time point, on otherwise osteogenic
substrates. Specifically, we found higher gene level expression of
BMP-2 on MG30-50 (mechanical gradients with elastic moduli
ranging from 30 to 50 kPa) collagen substrates, as well as on
mixed and collagen substrates that were stimulated with soluble
fibronectin. Direct measurements of BMP-2 secretion using
immunosorbance techniques were substantially higher on colla-
gen-presenting intermediate stiffness (i.e. tenogenic) substrates
compared to fibronectin. Exogenous BMP-2 stimulation at levels
similar to those observed in tenogenic cultures also interfered
with differentiation on otherwise osteogenic substrates, while
increasing cell proliferation. We thus conclude that BMP-2
secretion involved in BMSC differentiation can be modulated by
strategic choice of cell substrate. BMP-2 signaling has been
implicated in both osteogenic and tenogenic differentiation in
vivo [21], and we have demonstrated that substrate regulated,
paracrine BMP-2 signaling among local populations of BMSCs
could have implications to healing at the tendon-bone interface
where a tightly coordinated interaction of multiple cell pheno-
types is required.
Results
The mechanical compliance was determined to range from 10
to 150 kPa as a function of longitudinal position on the hydrogel
substrate (Fig. 1A). As reported earlier, there was negligible change
in mechanical properties after 14 days of cell culture compared to
baseline readings [14]. As we used a mixed ligand solution (type-I
collagen and fibronectin) and compared differentiation to collagen
and fibronectin functionalized substrates, bioactivity of substrates
was assessed using immunofluorescence to determine if differences
between the uniform and mixed ligand existed. As shown in
Fig. 1B, the normalized relative fluorescent units (RFUs) per unit
area of sample did not vary between the uniform and mixed ligand
conditions. These results indicate that using a mixed ligand
Figure 1. Characterization of cell culture interface. (A) The
substrate compliance was measured in 0.5 cm increments using
spherical indentation testing. Compliance was a linear function of
longitudinal position. (B) Schematic representation of (i) MG10–90
broad gradient substrates with outlined subregions representing those
analyzed after culture and (ii) narrow gradient subsection substrates. (C)
Immunosorbance techniques were used to measure the bioactivity of
substrates functionalized with fibronectin, collagen, or a mixed ligand
solution of both. Activity was relatively similar between the uniform and
mixed ligand conditions.
doi:10.1371/journal.pone.0031504.g001
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solution did not compromise the ligand bioactivity compared to
substrates functionalized with uniform ligand solutions.
We first probed BMSC differentiation on MG10-90 substrates
(moduli ranging from 10 to 90 kPa) that were functionalized with
fibronectin or type-I collagen at 10 mg/ml (Fig. 2). Cells were
seeded in growth media, and after 14 days, samples were assessed
for osteogenic differentiation with Alizarin Red staining of calcium
present in the matrix. This assay indicated the presence of
mineralized nodules on fibronectin functionalized MG10-90
substrates (Fig. 2A–C) that were not seen on collagen functiona-
lized MG10-90 substrates (Fig. 2D–F). When a mixed ligand
solution of type-I collagen and fibronectin (each at 10 mg/ml,
resulting in a bulk protein solution concentration of 20 mg/ml) was
used, nodules were not observed although a comparable amount
of fibronectin was present on the MG10-90 substrate (Fig. 2G–I).
Next, cells were seeded on fibronectin or collagen functionalized
MG10-90 substrates, but cultured in growth media supplemented
with type-I collagen for fibronectin functionalized MG10-90
substrates, or fibronectin for collagen functionalized MG10-90
substrates. Separate studies using media supplementation with
FITC conjugated collagen indicated that while some soluble
collagen precipitated onto the cells and passively bound to the
extracellular matrix, most was actively assembled into the fibrillar
matrix by the cells (data not shown). As with substrate bound type-
I collagen, soluble collagen also apparently interfered with
osteogenic differentiation (nodules were not seen on fibronectin
MG10-90 substrates (Fig. 2J–L)). Consistent with our collagen
functionalized MG10-90 substrates, we did not see nodules on
collagen MG10-90 substrates when the media was supplemented
with fibronectin (Fig. 2M–O).
We confirmed osteogenic differentiation by using quantitative
polymerase chain reaction (qPCR) to assess gene expression fold
change of Runx2 and alkaline phosphatase (Alpp). Higher levels
were seen on fibronectin MG10-90 substrates when cells were
cultured with growth media (Fig. 3A–B). This was consistent with
the Alizarin Red staining data. Fold changes comparable to
controls (BMSCs cultured on TCPS), or in some cases a down
regulation, were achieved on MG10-90 substrates for which
collagen was present either on the substrate or in the media. We
probed for tenogenic differentiation by assaying gene expression
for scleraxis (Sclx), a transcription factor expressed by cells
undergoing tenogenic differentiation, as well as tenomodulin
(Tnm), a protein expressed by tenocytes (Fig. 3C–D). Expression of
these two genes was altered on collagen presenting MG10-90
substrates but not fibronectin presenting MG10-90 substrates.
In contrast to fibronectin functionalized MG10-90 substrates,
the stiffest subregions of collagen functionalized MG10-90
substrates did not induce mineral plaques or gene level signaling
related to osteogenic differentiation. We did confirm that collagen-
functionalized subsections cut to isolate only the stiffest range of
gradient (MG70-90) did induce osteogenic differentiation when
cultured alone (Figs. 4,5). On fibronectin-substrates, mineral
plaques and associated osteogenic gene signaling were observed
on isolated mechanical gradients cultured independently using
both MG30-50 and MG70-90. We further noted that gene
expression on these fibronectin specific subsections was compara-
ble to corresponding subregions of the MG10-90 substrate. In the
case of subsectioned MG10-30 versus the corresponding subregion
of the intact MG10-90 substrates, there was a slight discrepancy in
gene expression: above one fold for MG10-30 subsections while
analogous subregions of intact MG10–90 substrates indicated fold
changes below one. We speculate that this may have been due to
paracrine effects across subregions of the MG10–90 substrates that
were absent in the MG10–30 subsection substrates.
Based on these results, we investigated the hypothesis that
tenogenic regions of the intact MG10–90 substrates (collagen
functionalized substrates, regions corresponding to 30–50 kPa)
were possibly interfering with osteogenic differentiation on stiffer
subregions through paracrine signaling of growth factors and
cytokines. To test this, we cultured subsections of the MG
substrate in the same well spanning the same stiffness range to
determine whether mineral plaques (osteogenic cells) could be
Figure 2. Differentiation from different culture conditions. Bone marrow stromal cells were cultured on MG10–90 substrates as described in
the text for 14 days and processed for osteogenic behavior. (A–C) On fibronectin substrates osteogenic behavior was indicated by nodule formation
on intermediate (,40 kPa) and stiffer (,80 kPa) subregions. (D–F) On collagen substrates osteogenic behavior was not seen. (G–I) When collagen
was presented in the media, osteogenic behavior was not seen on fibronectin substrates. (J–L) Fibronectin media presentation did not appear to alter
appearance of cells. (M–O) On mixed ligand substrates where the bulk ligand density was distributed using 20 mg/ml of total protein, osteogenic
differentiation was not observed. Scale bar represents 100 mm.
doi:10.1371/journal.pone.0031504.g002
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Figure 3. Markers of tenogenic and osteogenic differentiation from PCR. (A–B) Runx2 and alkaline phosphatase gene expression were
similarly regulated, confirming the presence of osteogenic cells on fibronectin substrates in the intermediate and stiff subregions (,40 and ,80 kPa,
respectively) of the intact MG10–90 substrate. (C–D) Scleraxis and tenomodulin expression confirmed tenogenic cells on the intermediate subregions
of collagen functionalized substrates. * statistical difference (p,0.05) compared to fold change from the MG10–90 substrate at ,20 kPa.
doi:10.1371/journal.pone.0031504.g003
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obtained on stiff collagen subsections (MG70–90) when cultured in
the same well as an intermediate compliance range (MG30–50)
fibronectin functionalized subsections. Similarly, we cultured the
stiff fibronectin subsection in the same well as the intermediate
compliance collagen substrate subsections. In these studies, we
found osteogenic plaques on the stiff collagen subsections (MG70–
90) when cultured with the intermediate stiffness fibronectin
subsection (MG30–50) (Fig. 6A–C). In contrast, osteogenesis was
absent (lack of plaques) on the stiff fibronectin substrate sections
when cultures of intermediate compliance collagen subsections
(MG30–50) were present (Fig. 6D–F). The MG70–90 substrates
also demonstrated increased cell proliferation behavior (Fig. 6G).
These results supported the hypothesis that paracrine signaling
was affecting substrate driven osteogenic differentiation within our
system.
Given its established primacy in tenogenic and osteogenic
differentiation [22,23], we then investigated signaling related to
bone morphogenetic protein-2 (BMP-2). First we probed the
expression at the gene level of both BMP-2 and Smad8, observing
increased expression with qPCR on intermediate stiffness (MG30–
50) collagen substrate sections compared to other conditions
(Figs. 7,8). Secreted BMP-2 was confirmed by colorimetric assay,
indicating increased presence of BMP-2 on substrates for which
elevated gene expression of BMP-2 was observed (Fig. 9). We
confirmed that BMP-2 supplementation at levels observed in
isolated subsection culture was sufficient to arrest osteoblastic
differentiation on substrate sections that were otherwise osteogenic
at day 14 (Fig. 10 A–D), with an accompanying BMP-2 induced
increase in cell proliferation (Fig. 10E).
Discussion
Cells sense the biochemical and mechanical properties of their
environment, and use these powerful cues to regulate their
function [24]. In the case of multipotent progenitor cells, these
cues can direct differentiation fate and kinetics [24]. At the
molecular level, matrix dependent signaling occurs, including
mitogen activated protein kinases (MAPKs), focal adhesion
elements, Rho GTPases, and transcription factors, all of which
can affect and modulate differentiation [16,20,25]. Previous
reports have demonstrated that by culturing stem cells on
substrates with moduli similar to those found in granulation
tissue, differentiation fate can be controlled [14,20]. Once
differentiated or in the process of differentiating, cells begin to
secrete growth factors and other proteins that can serve as soluble
cues in either autocrine or paracrine fashions to affect downstream
processes like extracellular matrix assembly [26,27]. With a long-
term view to apply these concepts in therapeutic strategies for
improving tendon to bone healing [28], our earlier work on cell
instructive culture substrates proved unable to simultaneously
induce osteogenic and tenogenic differentiation of BMSCs on the
same substrate [14]. We conjectured that cell-cell contacts or
paracrine signaling from tenogenic cells may have interfered with
osteogenic differentiation at remote sites of a mechanically
inhomogeneous substrate. In the present work we investigated
this hypothesis, and bring forth potential mechanisms for the
observed interference in osteogenic differentiation.
Soluble and insoluble cues from the microenvironment regulate
BMSC-mediated tissue modeling and remodeling in wound
healing processes. The established roles of BMSCs in healing are
twofold, whereby they first proliferate and differentiate to provide
cells that can regenerate damaged tissue [9]. The second role
regards paracrine signaling that coordinates local cellular response
to injury [9,10]. The secretion of growth factors, mitogens, and
other soluble factors by BMSCs is thus central to processes such as
matrix protein production, cell proliferation, and cell migration.
How paracrine signaling among local cell populations in the
system may affect progenitor cell differentiation by reducing
Figure 4. Differentiation on individual cultures of the gradient
subsections. (A, C) Similar to MG10–90 substrates, osteogenic plaques
were visualized on subsections of the fibronectin substrates. (B, D)
Morphologically, on the MG30–50 substrate cells appeared similar to
the corresponding region of the MG10–90 collagen substrate. However,
osteogenic plaques were evident on the MG70–90 substrate. Scale bar
represents 100 mm.
doi:10.1371/journal.pone.0031504.g004
Figure 5. Molecular assessment similar to staining experi-
ments. PCR assessed the expression of (A) Runx2 factor and (B)
scleraxis, which was expressed with trends consistent with the staining
data. * statistical difference (p,0.05) compared to MG10–30 culture
condition.
doi:10.1371/journal.pone.0031504.g005
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sensitivity to mechanical and biochemical cues is an area that
warrants investigation, and understanding potential intracellular
interactions is essential to understanding both why natural tendon
to bone healing processes are often inadequate, and how we may
design therapeutic biomaterials to augment healing [29].
We tested and confirmed our hypothesis that broad mechanical
gradient (MG) substrates (MG10–90) can elicit dramatic differences
Figure 6. Culture of soft, intermediate, and stiff subsections of the gradient within the same well. (A–C) Osteogenic behavior was seen
on the MG30–50 fibronectin substrate as well as the MG70–90 collagen substrate. (D–F) Morphologically the cells appeared similar to analogous
subregions of MG10–90 collagen substrate studies, however osteogenic plaques were not visualized on MG70–90 fibronectin substrates. Scale bar
represents 100 mm. (G) An increase in cell proliferation was observed on the osteogenic MG70–90 substrate (collagen functionalized) when co-
cultured with a tenogenic substrate compared to the osteogenic substrate alone. * statistical difference (p,0.05) between the two conditions.
doi:10.1371/journal.pone.0031504.g006
Figure 7. Smad8 and BMP-2 expression on MG10–90 sub-
strates. (A–B) Smad8 and BMP-2 were measured for gene level
expression, consistent with tenogenic gene expression (scleraxis and
tenomodulin) trends on these substrates. * statistical difference
(p,0.05) compared to fold change from the MG10–90 substrate at
,20 kPa.
doi:10.1371/journal.pone.0031504.g007
Figure 8. Substrate gene-level expression of Smad8 and BMP-2
from individual MG subsections. (A–B) Smad8 and BMP-2 were
assessed from individual (narrow range) MG subsection cultures, also
exhibiting trends similar to scleraxis from MG subsection studies
described earlier, with maximum expression on the MG30–50 collagen
substrate. * statistical difference (p,0.05) compared to MG10–30
culture condition.
doi:10.1371/journal.pone.0031504.g008
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in bone marrow stromal cell (BMSC) differentiation compared to
substrates with a narrower range (more uniform) of mechanical
properties. These differences further depended on ligand chemistry
and presentation. As in our previous work, we found that tenogenic
BMSC differentiation would only robustly occur on mechanical
gradient cell culture substrates within a narrow range of elastic
moduli (30–50 kPa) [14]. We refined this insight by demonstrating
that tenogenic differentiation further required the presence of
substrate-bound type-I collagen, and that tenogenesis was not
apparently inhibited by the presence of fibronectin in either
substrate-bound or soluble forms. Conversely, osteoblastic differ-
entiation on fibronectin substrates was inhibited by the presence of
collagen in either substrate-bound or soluble forms. Interestingly,
substrate-bound collagen could produce osteogenic cells, but only if
the substrate was both sufficiently stiff (,80 kPa) and there was no
presence of tenogenic substrates within the culture well. Collectively
these data suggest that tenogenic cells were interfering with
osteogenic differentiation through paracrine signaling. Whether
osteogenic differentiation is temporarily or indefinitely delayed
(following the shift to a more proliferative state) will be the focus of
future investigations into the signaling processes we discuss below.
Based on work by others demonstrating the sufficiency of
induced Smad-8/BMP-2 signaling to provoke tenogenic BMSC
differentiation [22,23], we focused on BMP-2 signaling as a
potentially key mediator of the observed behaviors. Perhaps the
most novel finding of the current work is that substrate mediated
BMP-2 signaling can affect BMSC proliferation and osteogenic
differentiation, whether cell secreted or supplemented to the
media. BMP-2 is part of the transforming growth factor-b (TGF-b)
superfamily of proteins and binds to the BMP receptor. Upon its
ligation with an appropriate ligand, various elements of the Smad
family are expressed in the cytoplasm before translocating to the
nucleus for the expression of appropriate transcription factors.
BMP-2 is well characterized to enhance differentiation in two-
dimensional systems, where stem cells are grown on plastic or glass
substrates with other soluble cues including dexomethasone, L-
ascorbic acid, and b-glycerophosphate, and its inhibition prevents
osteogenic differentiation [30]. However, recent reports highlight
the sensitivity of integrins and other cell surface receptors to
substrate compliance. For instance, BMP receptor expression has
been shown to increase on stiffer substrates, while softer substrates
promote uptake of receptors via endocytosis and repress surface
expression [31]. This change in surface expression could regulate
cell sensitivity to BMP levels in the microenvironment, and this
may underlie the observed shift to a more proliferative state rather
than differentiating. BMPs have been implicated in increased cell
proliferation [32,33,34,35], with some of these studies suggesting
that phosphorylated Smad activity after BMP receptor activation
promotes proliferation. Additional investigation of substrate
dependent BMP-2 signaling at various time points is required to
elucidate these mechanisms.
In tenogenic differentiation, it is apparently necessary to activate
scleraxis from Smad8; recent findings illustrate that BMP-2 is a
critical factor in Smad8 expression, both from cell expressed BMP-2
as well as exogenous application in soluble form [22]. In our work,
we activated scleraxis gene expression on collagen substrates
possessing an intermediate bulk elastic modulus (30–50 kPa). As
summarized above, substrate-bound collagen promoted tenogenic
differentiation, even in the presence of substrate-bound or soluble
fibronectin. Our previous studies showed higher degrees of BMSC
attachment and spreading on collagen substrates relative to
fibronectin [14]. Thus, in mixed ligand substrates (both collagen
and fibronectin bound to the substrate), BMSCs may preferentially
bind to type-I collagen. Whether this results in a down-regulation of
fibronectin binding receptor (e.g. a5b1 integrin) number or
engagement also represents grounds for future study. However,
with soluble collagen in a substrate-bound fibronectin system,
tenogenic differentiation did not occur. These findings align with
investigations by Fan and co-workers that have shown that
mesenchymal stem cells can respond differently to substrate
presented ligand compared to soluble ligand, with differentially
activated signaling pathways [36]. Our findings thus support that
scleraxis and other transcription factors are critically regulated by
ligand-integrin binding, with certain key effects of collagen-induced
signaling not being triggered by soluble ligand presentation.
The culture of subsections within the same well performed in
this study were designed to address paracrine signaling and rule
out cell-cell contact involvement in the altered osteogenic
differentiation patterns observed using subsections of the broader
range MG substrates (MG10–90). Central to these studies were the
tenogenic subsections (collagen functionalized MG30–50) and
their influence on other substrate sections (or subregions of the
MG10–90) by secretion of soluble cues. While we did include the
MG10–30 substrate sections in the culture to more fully replicate
the intact MG10–90 cultures, our reporting here focuses on the
influence of the MG30–50 collagen functionalized substrate. As
indicated by baseline levels of Runx2 and scleraxis expression in
quantitative PCR analysis of the ,20 kPa region of both intact
and sectioned substrates, behavior of cells on the ,20 kPa region
of intact MG10–90 substrates differed somewhat from those on the
isolated MG10–30 subsections – an effect we attribute to paracrine
effects from other subregions of the intact substrates. However, we
presume that these effects had little bearing on the interpretation
of results from the culture of multiple subsections representing the
overall mechanical gradient, since cell behaviors on stiffer
substrates (40 kPa and above) were otherwise fully consistent
between subregions of the intact MG10–90 substrates and
analogous subsections with a narrower range of moduli.
While two dimensional in vitro cell and tissue culture systems
remain an indispensable tool for shedding first light on the cell
mechanics modulation of cell function [14,20,37], BMSCs in vivo
are ensconced in a three-dimensional matrix composed of various
proteins including fibronectin and collagen, and are further
susceptible to cues from a large range of cell phenotypes resident
in the tissue. In the present work, we assessed the role of paracrine
signaling between cells stemming from a single phenotype within a
highly-controlled two-dimensional system. While two-dimensional
Figure 9. Assessing BMP-2 secretion. BMP-2 expression was
assessed from individual cultures of MG subsections secreted in the
media, which was expressed at a higher level on MG30–50 collagen
substrates. * statistical difference (p,0.05) compared to 40 kPa fibronectin
condition.
doi:10.1371/journal.pone.0031504.g009
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substrates can lack important spatial cues that affect cell signaling
and behavior [38], analogous three-dimensional cell culture systems
often lack quantitative control with regard to matrix mechanics and
ligand presentation. Aside from three-dimensional cues, the present
study also neglects transient mechanical loads that would act on the
healing tendon-bone junction, and further exclude the influence
that inflammatory or fibrocartilage cell phenotypes could have on
system behavior. All of these simplifying limitations can be
addressed in later (more complex) experimental designs, with the
results of the present study laying a necessary foundation. In other
words, we believe that the present study establishes important
guiding principles for evolving biomaterial engineering approaches
to study tenogenic and osteogenic differentiation of mesenchymal
progenitor cells, particularly in terms of the interactions between
relative matrix composition, matrix mechanics, and intracellular
signaling. Accounting for these interactions in three dimensional
systems with multiple cell types represents experimentally challeng-
ing but necessary future work.
In summary, our data show that BMSC differentiation can
dramatically differ for cells cultured on substrates with broad
regional differences in mechanical properties, compared to more
narrow gradient substrate cultures. More specifically, tenogenic
differentiation of bone mesenchymal stromal cells seems to
interfere with osteogenic differentiation at a 14 day time point
on otherwise osteogenic substrates, inducing a more proliferative
state. This is apparently related to cell secreted cues, such as BMP-
2, that may regulate intracellular coordination of stromal cell
populations at the healing tendon to bone interface.
Figure 10. Arrest of osteogenic differentiation at day 14. (A–D) Individual culture of MG subsections supplemented with BMP-2 in the media
no longer procured osteogenic plaques. Scale bar represents 100 mm. (E) The Alamar blue assay demonstrated an increase in cell proliferation on
collagen functionalized osteogenic substrates (MG70–90) treated with BMP-2. * statistical difference (p,0.05) between two conditions.
doi:10.1371/journal.pone.0031504.g010
Substrate Driven Differentiation to Tendon/Bone
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Methods
Substrate Characterization and Preparation
NuPage 4–12% electrophoresis gels (Invitrogen) were used as the
substrate, with reproducible mechanical properties previously
characterized and described by us [14]. The substrate has a nearly
linear gradient of elastic modulus, with moduli ranging from 10 kPa
to over 150 kPa. Regions with a range of moduli from 10 to 90 kPa
(MG10–90) were sectioned and placed in a six well plate. For studies
that examined individual subsections of the gradient, appropriate
subsections were extracted, spanning a proportionally smaller
region of the gradient. For studies that examined subsections within
the same culture, subsections were sectioned and placed on a well
with a small drop of Norland optical adhesive. The substrates were
then exposed to UV light in a Stratalinker 2400 crosslinker
(Stratagene) for 10 minutes. All substrates were then overlaid with
sulfo-SANPAH (Pierce Biotech), a light sensitive crosslinker, at
0.5 mg/ml in 50 mM HEPES buffer (Sigma) and exposed to
ultraviolet light in the crosslinker as previously described [37]. The
crosslinker was removed and the substrates were overlaid with fresh
crosslinker and exposed to ultraviolet light. The well plates were
then covered and exposed to ultraviolet light for 15 minutes. At this
point the substrates and well plates were sterilized and then brought
back to the sterile field for further processing.
Fibronectin, collagen I (Sigma), or a mixed solution of collagen
and fibronectin at 10 mg/ml each was overlaid, incubated
overnight, washed, and used afterwards for cell culture experiments.
Different regions of the MG substrates were previously found to
have equivalent ligand distributions as determined from immuno-
fluorescence [14], and the MG30–50 substrate was used in the
present study for bioactivity immunosorbance assays for collagen
and fibronectin compared to the mixed ligand solution. Functio-
nalized substrates were blocked with 1% bovine serum albumin
(Sigma) for 1 hour at 37uC, washed, and overlaid with either rabbit
anti-human fibronectin diluted 1:500 or mouse anti-collagen diluted
1:1000 (Sigma) overnight at 4uC. Substrates were washed and
overlaid with the appropriate FITC-conjugated donkey secondary
antibody (Jackson Immunolabs) diluted 1:200 for 1 hour at room
temperature. Substrates were washed, sectioned, measured, and
transferred to a 96 well plate to quantify relative fluorescence units
(RFUs) on a Spectra Max GeminiXS (Molecular Devices).
Isotherms were established by normalizing RFUs to area of
samples. Experiments were performed in duplicates three times.
Cell Culture
Bone marrow stromal cells (BMSCs) were a kind gift from Dr.
Simon Hoerstrup’s lab (University of Zurich) and had been first
verified in that laboratory for multipotency in osteogenic,
adipogenic, and chondrogenic induction assays [39]. In the cells
used in these experiments, we verified an undifferentiated state by
probing CD73, CD90, and CD105 as positive markers and CD34
as a negative marker using polymerase chain reaction (PCR) and
normalizing expression to Gapdh. These multipotent stromal cells
were cultured in growth media, based in alpha MEM (Invitrogen)
and supplemented with 10% fetal calf serum and 1% penicillin/
streptomycin (both Invitrogen). Media was exchanged every three
days and maintained at 37uC with 5% CO2. Cells were used just
before confluence. A cell suspension was created from near-
confluent flasks by washing cells with PBS, overlaying with trypsin
and neutralizing with growth media.
Differentiation
A cell suspension was created as described above, and 25,000
cells/cm2 were seeded and cultured for 14 days at 37uC with
media changes every three days. In some cases, media was
supplemented with collagen or fibronectin at a final concentration
of 10 mg/ml to examine the effect of soluble stimulation on
fibronectin substrates or collagen substrates, respectively, as well as
bone morphogenic protein-2 (BMP-2). At the 14 day time point,
substrates were gently washed with PBS three times, and cells were
fixed with 10% formaldehyde (Sigma) for 20 minutes at room
temperature. The fixative was removed and substrates were
carefully washed with distilled water three times. The substrates
were then overlaid with 2% Alizarin Red (Sigma) (pH=4.2) to
stain for calcium present in the culture. The solution was
incubated for 10 minutes at room temperature before being
washed three times with distilled water. Images were acquired with
a Nikon E600 upright microscope with a 106objective. For each
region of the MG10–90 substrate (20, 40, and 80 kPa) or
individual subsections of the MG substrates and ligand/culture
condition, at least five non-overlapping fields were imaged.
Experiments were performed three times.
Polymerase Chain Reaction
Two markers of osteogenic differentiation and two markers for
tenogenic differentiation were evaluated at day 14 of stromal cell
culture by implementing reverse transcriptase polyermase chain
reaction (RT-PCR). Substrates were prepared as described above,
BMSCs were cultured at 25,000 cells/cm2, and the total RNA was
extracted using an RNeasy Kit (Qiagen) as per the manufacturer’s
protocols, and stored at 280uC until use. In the analysis of MG
substrates (20–80 kPa), substrates were sectioned into three regions
prior to isolating RNA. The cDNA was generated by using a
cDNA Reverse Transcription Kit (Applied Biosystems). PCR was
performed on resultant cDNA using SYBR green PCR Master
Mix (SABiosciences) and upper and lower primers. Osteogenic
markers probed included for alkaline phosphatase (Alpp), an
enzyme expressed by osteoblasts [40,41], runt-related transcrip-
tion factor 2 (Runx2), a transcription factor for osteoblast
differentiation [42,43]. Scleraxis (Sclx), a transcription factor for
tenoblasts [22,44,45], and tenomodulin (Tnm), a structural protein
involved in collagen fibril maturation [46,47,48] were probed as
markers of tenogenic differentiation. We also probed the gene level
expression of BMP-2 and Smad8. Glyceraldehyde-3-phosphate
dehydrogenase (Gapdh) was used as a housekeeping gene. A
Roche Light Cycler (Roche), was utilized for fluorescent detection
after each amplification cycle. The average threshold cycle
number was used to calculate fold-changes in mRNA with control
samples from cells cultured on tissue culture polystyrene from the
control samples using the –DDCT [49].
Alamar Blue Assay
The Alamar blue assay is designed to measure cell proliferation
from different culture conditions by conversion of nonfluorescent
resazurin to fluorescent resorufin in living cells [50]. BMSCs were
seeded at 25,000 cells/cm2 on MG70–90 collagen subsections,
MG70–90 collagen substrates supplemented with BMP-2 in the
media, and coculture of MG30–50 and MG70–90 substrates. Cells
were cultured for 4 days, at which point they were trypsinized to
release cells, neutralized, centrifuged for 6 minutes at 900 rpm,
and resuspended in 150 ml of media. The cell suspension was
plated in a 96 well plate, along with two freshly seeded wells at a
seeding density of 25,000 cells/cm2. Cells were given 24 hours to
settle before treating with media supplemented with 10% Alamar
blue reagent (Invitrogen) for an additional 24 hours. As a control,
prior to Alamar blue treatment one well with untreated cells was
fixed for 15 minutes with formaldehyde. Readings were taken on a
Spectra Max GeminiXS fluorescent plate reader with 570 nm
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excitation and emission readings at 600 nm, standardized to
substrate culture area and normalized to the emission reading for
untreated cells on tissue culture polystyrene.
BMP-2 Secretion
Bone morphogenic protein-2 (BMP-2) secretion was assessed
using a colorimetric ELISA (R&D Systems). The ELISA uses well
plates that are pre-coated with a monoclonal antibody specific for
BMP-2. Briefly, a standard curve, ranging from 4 ng/ml to 0 ng/
ml, was created from stock BMP-2 at 1 mg/ml and diluted with
the provided dilution buffer. The standard curve and samples were
overlaid in the pre-coated well plates with a provided assay
diluent. The wells were incubated for two hours with agitation at
room temperature, and washed four times with the provided wash
buffer. Between each wash, the wells were shaken against paper
towels and aspirated with a pipet to ensure complete removal of
unreacted species. Next, a monoclonal antibody solution was
prepared from the provided stock solution that binds to BMP-2
that is conjugated to an enzyme, overlaid on substrates, and
incubated for two hours with agitation at room temperature. After
washing substrates to remove any unbound antibody-enzyme
reagent, a substrate solution was prepared from the provided kit
and added to the wells. The color develops in proportion to the
amount of BMP-2 bound in the initial step. The development is
stopped with the stopping solution and read at 450 nm. Optical
density readings were converted to concentrations from the best fit
linear line to the standard curve.
Statistics
All experiments were performed three times. Statistics were
performed with single-factor analysis of variance (ANOVA), and a
confidence level of 95% (p#0.05) was considered necessary for
statistical significance. All error bars represent the standard error
around the mean.
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